Effect of micronutrient supplementation on diarrhoeal disease among stunted children in rural South Africa
- PMID: 19174830
- PMCID: PMC2705811
- DOI: 10.1038/ejcn.2008.78
Effect of micronutrient supplementation on diarrhoeal disease among stunted children in rural South Africa
Abstract
Background/objective: The efficacy of zinc combined with vitamin A or multiple micronutrients in preventing diarrhoea is unclear in African countries with high prevalence of human immunodeficiency virus (HIV)-exposed children. Potential modifying factors, such as stunting, need to be addressed. The objective of this study was to determine whether adding zinc or zinc plus multiple micronutrients to vitamin A reduces diarrhoea incidence, and whether this differs between the strata of stunted or HIV-infected children.
Methods: We analyzed data from a randomized, controlled, double-blinded trial (ClinicalTrials.gov NCT00156832) of prophylactic micronutrient supplementation to children aged 6-24 months. Three cohorts of children: 32 HIV-infected children, 154 HIV-uninfected children born to HIV-infected mothers and 187 uninfected children born to HIV-uninfected mothers, received vitamin A, vitamin A plus zinc or multiple micronutrients, which included vitamin A and zinc. The main outcome was incidence of diarrhoea. Poisson regression was used in intent-to-treat analyses. Stratified analyses followed testing for statistical interaction between intervention and stunting.
Results: We observed no significant differences in overall diarrhoea incidence among treatment arms. Stunting modified this effect with stunted HIV-uninfected children having significantly lower diarrhoea incidence when supplemented with zinc or multiple micronutrients compared with vitamin A alone (2.04 and 2.23 vs 3.92 episodes/year, respectively, P=0.024). No meaningful subgroup analyses could be done in the cohort of HIV-infected children.
Conclusions: Compared with vitamin A alone, supplementation with zinc and with zinc and multiple micronutrients, reduced diarrhoea morbidity in stunted rural South African children. Efficacy of zinc supplementation in HIV-infected children needs confirmation in studies that represent the spectrum of disease severity and age groups.
Conflict of interest statement
KA Luabeya, N Mpontshane, J Van den Broeck and M L Bennish all received salary and travel support form the National Institutes of Health.
Figures
References
-
- Baqui AH, Zaman K, Persson LA, El Arifeen S, Yunus M, Begum N, et al. Simultaneous weekly supplementation of iron and zinc is associated with lower morbidity due to diarrhea and acute lower respiratory infection in Bangladeshi infants. J Nutr. 2003;133(12):4150–4157. - PubMed
-
- Bhutta ZA, Bird SM, Black RE, Brown KH, Gardner JM, Hidayat A, et al. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr. 2000;72(6):1516–1522. - PubMed
-
- Bobat R, Coovadia H, Stephen C, Naidoo KL, McKerrow N, Black RE, et al. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet. 2005;366(9500):1862–1867. - PubMed
-
- Brown KH, Rivera JA, Bhutta Z, Gibson RS, King JC, Lonnerdal B, et al. International Zinc Nutrition Consultative Group (IZiNCG) technical document #1. Assessment of the risk of zinc deficiency in populations and options for its control. Food Nutr Bull. 2004;25(1 Suppl 2):S99–S203. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- D43 TW005571/TW/FIC NIH HHS/United States
- D43TW05572-01/TW/FIC NIH HHS/United States
- D43 TW001277/TW/FIC NIH HHS/United States
- D43-TW001277-11/TW/FIC NIH HHS/United States
- K24 AI001671/AI/NIAID NIH HHS/United States
- 063009/WT_/Wellcome Trust/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- U01 HD038900/HD/NICHD NIH HHS/United States
- U01 AI058371/AI/NIAID NIH HHS/United States
- 62925/WT_/Wellcome Trust/United Kingdom
- 1 K24 AI/HDO1671-01/AI/NIAID NIH HHS/United States
- D43 TW005572/TW/FIC NIH HHS/United States
- 1 UO1 AI45508-01/AI/NIAID NIH HHS/United States